SCHEMBL7724071

SCHEMBL7724071

O=C(O)C1=C2C=CC=CC2C=Cc2ccccc21

nearest known ligand 0.32

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 1/20 0.32
FGFR2 P21802 1/20 0.32
FGFR4 P22455 1/20 0.32
FGFR3 P22607 1/20 0.32
MAPT P10636 1/20 0.30
ALOX15 P16050 1/20 0.30
HTT P42858 1/20 0.30
HBB P68871 1/20 0.30
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5685518 0.87 FGFR1 (0.33) FGFR1FGFR2FGFR4FGFR3
SCHEMBL5045911 0.78
SCHEMBL17923692 0.77 ALDH1A1 (0.32) MAPTALOX15HTTMEN1KMT2A
SCHEMBL11176419 0.74
SCHEMBL9205277 0.74
SCHEMBL5850276 0.72
SCHEMBL6682147 0.72 CYP3A4 (0.31)
SCHEMBL13632710 0.70 GAA (0.34) FGFR1FGFR2FGFR4FGFR3MAPT
SCHEMBL11183086 0.69
SCHEMBL6192010 0.66

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6468998-B1 ANTAGONIZE SEROTONIN 2 RECEPTORS, SUPPRESS PLATELET AGGREGATION, IMPROVE PERIPHERAL CIRCULATION AND PROMOTE LACHRYMATION MITSUBISHI PHARMA CORPORATION (JP) 2002-10-22 US disclosed
EP-1125922-A1 PYRROLIDINE COMPOUNDS AND MEDICINAL UTILIZATION THEREOF Welfide Corporation (JP) 2001-08-22 EP disclosed